Anna Volkmer, Emily Viega Alves, Hagit Bar-Zeev, Elena Barbieri, Petronilla Battista, Ashleigh Beales, Barbara Costa Beber, Emilie Brotherhood, Ines Ribeiro Cadorio, Maria Teresa Carthery-Goulart, Jade Cartwright, Sebastian Crutch, Karen Croot, Maria Isabel d'Ávila Freitas, Jeanne Gallée, Stephanie M. Grasso, Katarina Haley, Heleen Hendriksen, Shalom Henderson, Lize Jiskoot, Isabel Junqueira Almeida, Jackie Kindell, Rachel Kingma, Lorinda L Y Kwan-Chen, Monica Lavoie, Adi Lifshitz-Ben-Basat, Regina Jokel, Aurore Mahut-Dubos, Jordi A. Matias-Guiu, Michèle Masson-Trottier, Marcus Meinzer, Ellen McGowan, Carolina Mendez-Orellana, Aaron M. Meyer, Carly Millanski, Núria Montagut, Aimee Mooney, Darby J. Morhardt, Lyndsey Nickels, Monica Norvik, Iris Edda Nowenstein, Avanthi Paplikar, Margaret Pozzebon, Antoine Renard, Leanne Ruggero, Emily Rogalski, Anna U. Rysop, Fredrik Sand Aronsson, Aida Suárez-González, Sharon Savage, Mai Tran Thi, Kyriana Tsapkini, Cathleen Taylor-Rubin, Donna C. Tippett, Nina Unger, Lizet van Ewijk, Sandra Wielaert, Ingvild Elisabeth Winsnes, Anne Whitworth, Ibrahim Can Yasa, David Copland, Maya L. Henry, Jason D. Warren, Rosemary Varley, Sarah J. Wallace, Chris J. D. Hardy
4 min
Primary progressive aphasia (PPA) is a neurodegenerative condition characterized by a gradual decline in language abilities. Historically, intervention research has relied heavily on word accuracy as a primary outcome measure. However, people living with PPA and their care partners have frequently reported that these measures do not capture the communication challenges that matter most to their daily lives. This study aimed to develop a Core Outcome Set (COS-PPA) to standardize how communication interventions are evaluated, ensuring that research outcomes are more relevant to patients and their families.
Following the Core Outcome Set Standards for Development Recommendations (COSSTAD), the researchers conducted a three-stage process. First, a systematic review identified 84 existing outcome measurement instruments used in PPA intervention literature. Second, international consensus groups—involving 82 people with PPA and 91 care partners—used a nominal group technique to identify the most important communication constructs. Finally, a modified e-Delphi consensus exercise with 57 international researchers was conducted to reach agreement on these core constructs and potential measurement tools.
The study successfully identified five core outcome constructs that are prioritized by both patients and their families: participating in conversations with family and friends, getting words out, being more fluent, conveying a message by any means, and understanding what others are saying. While there was strong agreement on these constructs, the researchers could not reach a consensus on which specific measurement instruments should be used to assess them. This indicates that while the field now has a shared language for what to measure, it lacks a standardized agreement on how to measure it.
By defining a core outcome set, this research provides a roadmap for future clinical trials to focus on patient-centered goals rather than narrow linguistic metrics. This shift is essential for improving the comparability of intervention studies and ensuring that the results of clinical research are meaningful to the people living with PPA. The findings highlight a critical gap in the field: the need for the development and validation of new assessment tools that can accurately capture these five core constructs in a progressive, neurodegenerative context.
Sam: And what did patients say they cared most about?
Alex: Things like: being able to take part in a conversation, getting their message across by whatever means works — whether that's words, gestures, or pointing — and being able to understand what others are saying to them. The common thread is function. Not "can you name this object" but "can you connect with another person."
Sam: That's a meaningful shift in perspective. It's the difference between a doctor asking "how's your blood pressure reading?" versus "are you able to live the life you want to live?"
Alex: That's a good way to put it. And this matters enormously for research. If future clinical trials all use this shared scorecard, scientists can finally pool their data, compare treatments directly, and build a clearer picture of what actually helps people with PPA.
Sam: So does this new scorecard come with the tools to measure those things? Like, do they now have a test for "ability to participate in conversation"?
Alex: This is where the paper is careful to flag its own limitations. They reached a strong consensus on what to measure — the outcomes themselves. But they couldn't yet agree on which specific tests or instruments are best for capturing those outcomes. That work is still ahead.
Sam: So they've successfully moved the goalposts to the right place, but the measuring tape to reach those goalposts is still being designed.
Alex: That's a precise way to describe it. The paper represents the first international consensus on what success in PPA treatment should actually look like. It's a foundational step — one that reorients the entire field around the patient's lived experience rather than a clinician's test score. The next stage is developing and validating the tools that can reliably measure those agreed-upon outcomes.
Sam: And until those tools exist, researchers at least know they're all pointing in the same direction.
Alex: Exactly. Agreement on the destination is a necessary first step before you can build the road. Thanks for listening to ResearchPod.